The Europe DNA sequencing market is projected to record a CAGR of 17.23% during the forecast period, 2021-2028. The high market growth potential is attributed to the ongoing developments in DNA sequencing techniques and the key strategies of well-established players to increase their market shares.

EUROPE DNA SEQUENCING MARKET FORECAST 2021-2028

Europe Market by Technology ( Sequencing by Synthesis, Ion Semiconductor Sequencing, Chain Termination Sequencing, Pyrosequencing, Sequencing by Ligation (Sbl), Single-molecule Real-time Sequencing (Smrt), Nanopore Sequencing, Other Technologies ) Market by Application ( Biomarker Discovery, Diagnostics, Reproductive Health, Personalized Medicine, Drug Discovery, Agriculture & Animal Research, Forensics, Other Applications ) Market by Product ( Instruments & Consumables, Sequencing Services, Bioinformatics ) Market by End-user ( Research Centers and Academic & Government Institutes, Pharmaceutical, Biotechnology Companies, Hospitals & Clinics, Other End-users ) by Geography.

Request free sample

The Europe DNA sequencing market is projected to record a CAGR of 17.23% during the forecast period, 2021-2028. The high market growth potential is attributed to the ongoing developments in DNA sequencing techniques and the key strategies of well-established players to increase their market shares.europe-dna-sequencing-market

To know more about this report, request a free sample copy.

The Europe DNA sequencing market growth assessment includes evaluating the United Kingdom, Poland, France, Germany, Belgium, Russia, Italy, and Rest of Europe. The thriving healthcare industry drives the market growth in the United Kingdom. DNA sequencing platforms are majorly utilized in academic laboratories and research facilities in the UK. Also, government agencies and private investors are investing in R&D. DNA sequencings are expected to be used increasingly during the forecast period, given the huge number of reimbursement facilities for healthcare. Such aspects project the increased use of next-generation sequencing in healthcare for diagnostics. Moreover, a COVID-19 genome sequencing alliance was formed in March 2020, for large-scale analysis of the virus.

In Italy, pharmaceutical and biotechnology companies are making significant investments, along with expanding their market shares, to cater to the growing DNA sequencing demands. The R&D sector’s fast-paced growth is set to contribute to market growth, along with the industry-wide collaborations focused on diversified applications and research activities. Such factors are expected to propel market growth.

Merck KGaA is a pharmaceutical company with business operations in the pharmaceutical, life science, and chemical industries under four divisions. The product portfolio includes small molecules, biopharmaceuticals, liquid crystals, and life science & performance chemicals. The company has its headquarters in Darmstadt, Germany.

 

To request a free sample copy of this report, please complete the form below:

We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

    1. RESEARCH SCOPE & METHODOLOGY
      • STUDY OBJECTIVES
      • SCOPE OF STUDY
      • METHODOLOGY
      • ASSUMPTIONS & LIMITATIONS
    2. EXECUTIVE SUMMARY
      • MARKET SIZE & ESTIMATES
      • MARKET OVERVIEW
    3. MARKET DYNAMICS
      • KEY DRIVERS
        • INCREASING NEED FOR DNA SEQUENCING IN ANIMALS & PLANT REPRODUCTION
        • TECHNOLOGICAL DEVELOPMENTS
        • GROWING RESEARCH AND DEVELOPMENT IN DNA SEQUENCING
        • PREVALENCE OF CANCER CASES
        • USAGE OF LIQUID BIOPSY APPLICATIONS
        • IMPLEMENTATION OF GENOME MAPPING PROGRAMS
      • KEY RESTRAINTS
        • ACCURACY AND STANDARDIZATION CONCERNS IN DIAGNOSTIC TESTING
        • LIMITATIONS IN BIOINFORMATICS
        • SOCIAL AND ETHICAL ISSUES
    1. KEY ANALYTICS
      • IMPACT OF COVID-19 ON DNA SEQUENCING MARKET
      • KEY MARKET TRENDS
      • PORTER’S FIVE FORCES ANALYSIS
        • BUYERS POWER
        • SUPPLIERS POWER
        • SUBSTITUTION
        • NEW ENTRY
        • INDUSTRY RIVALRY
      • OPPORTUNITY MATRIX
      • VENDOR LANDSCAPE
      • VALUE CHAIN ANALYSIS
      • KEY BUYING CRITERIA
    2. MARKET BY TECHNOLOGY
      • SEQUENCING BY SYNTHESIS
      • ION SEMICONDUCTOR SEQUENCING
      • CHAIN TERMINATION SEQUENCING
      • PYROSEQUENCING
      • SEQUENCING BY LIGATION (SBL)
      • SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
      • NANOPORE SEQUENCING
      • OTHER TECHNOLOGIES
    3. MARKET BY APPLICATION
      • BIOMARKER DISCOVERY
      • DIAGNOSTICS
      • REPRODUCTIVE HEALTH
      • PERSONALIZED MEDICINE
      • DRUG DISCOVERY
      • AGRICULTURE & ANIMAL RESEARCH
      • FORENSICS
      • OTHER APPLICATIONS
    4. MARKET BY PRODUCT
      • INSTRUMENTS & CONSUMABLES
        • INSTRUMENTS & CONSUMABLES TYPE
          • CONSUMABLES
          • INSTRUMENTS
        • INSTRUMENTS & CONSUMABLES PLATFORM
          • NGS (NEXT GENERATION SEQUENCING)
            • RNA SEQUENCING
            • TARGETED RESEQUENCING
            • WHOLE-EXOME SEQUENCING
            • WHOLE-GENOME SEQUENCING
            • CHIP SEQUENCING
            • DE NOVO SEQUENCING
            • METHYL SEQUENCING
          • SANGER
        • SEQUENCING SERVICES
        • BIOINFORMATICS
    1. MARKET BY END-USER
      • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
      • PHARMACEUTICAL
      • BIOTECHNOLOGY COMPANIES
      • HOSPITALS & CLINICS
      • OTHER END-USERS
    2. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. COMPETITIVE LANDSCAPE
      • KEY STRATEGIC DEVELOPMENTS
        • MERGERS & ACQUISITIONS
        • PRODUCT LAUNCHES & DEVELOPMENTS
        • PARTNERSHIPS & AGREEMENTS
        • BUSINESS EXPANSIONS, ANNOUNCEMENTS, AND DIVESTITURES
      • COMPANY PROFILES
        • ADAPTIVE BIOTECHNOLOGIES INC
        • AGILENT TECHNOLOGIES INC
        • ASURAGEN INC
        • BGI GENOMICS
        • BIO-RAD LABORATORIES INC
        • DANAHER CORPORATION (INTEGRATED DNA TECHNOLOGIES INC)
        • EUROFINS SCIENTIFIC
        • HOFFMANN-LA ROCHE
        • ILLUMINA INC
        • MERCK KGAA
        • PACIFIC BIOSCIENCES OF CALIFORNIA INC
        • PERKINELMER INC
        • SIEMENS HEALTHINEERS AG
        • SPIRAL GENETICS INC
        • THERMO FISHER SCIENTIFIC INC
        • UBIQUITY GENOMICS INC

    LIST OF TABLES

    TABLE 1: MARKET SNAPSHOT – DNA SEQUENCING

    TABLE 2: EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 3: EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 4: EUROPE DNA SEQUENCING MARKET, BY APPLICATION, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 5: EUROPE DNA SEQUENCING MARKET, BY APPLICATION, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 6: EUROPE DNA SEQUENCING MARKET, BY PRODUCT, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 7: EUROPE DNA SEQUENCING MARKET, BY PRODUCT, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 8: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 9: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 10: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 11: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY PLATFORM, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 12: EUROPE NGS MARKET, BY TYPE, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 13: EUROPE NGS MARKET, BY TYPE, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 14: EUROPE DNA SEQUENCING MARKET, BY END-USER, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 15: EUROPE DNA SEQUENCING MARKET, BY END-USER, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 16: EUROPE DNA SEQUENCING MARKET, BY COUNTRY, HISTORICAL YEARS, 2016-2020 (IN $ MILLION)

    TABLE 17: EUROPE DNA SEQUENCING MARKET, BY COUNTRY, FORECAST YEARS, 2021-2028 (IN $ MILLION)

    TABLE 18: LEADING PLAYERS OPERATING IN EUROPE DNA SEQUENCING MARKET

    TABLE 19: LIST OF MERGERS & ACQUISITIONS

    TABLE 20: LIST OF PRODUCT LAUNCHES & DEVELOPMENTS

    TABLE 21: LIST OF PARTNERSHIPS & AGREEMENTS

    TABLE 22: LIST OF BUSINESS EXPANSIONS, ANNOUNCEMENTS & DIVESTITURES

    LIST OF FIGURES

    FIGURE 1: LIMITATIONS OF DNA SEQUENCING IN DIAGNOSTIC TESTING

    FIGURE 2: KEY MARKET TRENDS

    FIGURE 3: PORTER’S FIVE FORCES ANALYSIS

    FIGURE 4: OPPORTUNITY MATRIX

    FIGURE 5: VENDOR LANDSCAPE

    FIGURE 6: EUROPE DNA SEQUENCING MARKET, BY TECHNOLOGY, IN 2020

    FIGURE 7: EUROPE DNA SEQUENCING MARKET, BY SEQUENCING BY SYNTHESIS, 2021-2028 (IN $ MILLION)

    FIGURE 8: EUROPE DNA SEQUENCING MARKET, BY ION SEMICONDUCTOR SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 9: EUROPE DNA SEQUENCING MARKET, BY CHAIN TERMINATION SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 10: EUROPE DNA SEQUENCING MARKET, BY PYROSEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 11: EUROPE DNA SEQUENCING MARKET, BY SEQUENCING BY LIGATION (SBL), 2021-2028 (IN $ MILLION)

    FIGURE 12: EUROPE DNA SEQUENCING MARKET, BY SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT), 2021-2028 (IN $ MILLION)

    FIGURE 13: EUROPE DNA SEQUENCING MARKET, BY NANOPORE SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 14: EUROPE DNA SEQUENCING MARKET, BY OTHER TECHNOLOGIES, 2021-2028 (IN $ MILLION)

    FIGURE 15: EUROPE DNA SEQUENCING MARKET, BY APPLICATION, IN 2020

    FIGURE 16: EUROPE DNA SEQUENCING MARKET, BY BIOMARKER DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 17: EUROPE DNA SEQUENCING MARKET, BY DIAGNOSTICS, 2021-2028 (IN $ MILLION)

    FIGURE 18: EUROPE DNA SEQUENCING MARKET, BY REPRODUCTIVE HEALTH, 2021-2028 (IN $ MILLION)

    FIGURE 19: EUROPE DNA SEQUENCING MARKET, BY PERSONALIZED MEDICINE, 2021-2028 (IN $ MILLION)

    FIGURE 20: EUROPE DNA SEQUENCING MARKET, BY DRUG DISCOVERY, 2021-2028 (IN $ MILLION)

    FIGURE 21: EUROPE DNA SEQUENCING MARKET, BY AGRICULTURE & ANIMAL RESEARCH, 2021-2028 (IN $ MILLION)

    FIGURE 22: EUROPE DNA SEQUENCING MARKET, BY FORENSICS, 2021-2028 (IN $ MILLION)

    FIGURE 23: EUROPE DNA SEQUENCING MARKET, BY OTHER APPLICATIONS, 2021-2028 (IN $ MILLION)

    FIGURE 24: EUROPE DNA SEQUENCING MARKET, BY PRODUCT, IN 2020

    FIGURE 25: EUROPE DNA SEQUENCING MARKET, BY INSTRUMENTS & CONSUMABLES, 2021-2028 (IN $ MILLION)

    FIGURE 26: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY CONSUMABLES, 2021-2028 (IN $ MILLION)

    FIGURE 27: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY INSTRUMENTS, 2021-2028 (IN $ MILLION)

    FIGURE 28: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY NGS, 2021-2028 (IN $ MILLION)

    FIGURE 29: EUROPE NGS MARKET, BY RNA SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 30: EUROPE NGS MARKET, BY TARGETED RESEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 31: EUROPE NGS MARKET, BY WHOLE-EXOME SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 32: EUROPE NGS MARKET, BY WHOLE-GENOME SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 33: EUROPE NGS MARKET, BY CHIP SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 34: EUROPE NGS MARKET, BY DE NOVO SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 35: EUROPE NGS MARKET, BY METHYL SEQUENCING, 2021-2028 (IN $ MILLION)

    FIGURE 36: EUROPE INSTRUMENTS & CONSUMABLES MARKET, BY SANGER, 2021-2028 (IN $ MILLION)

    FIGURE 37: EUROPE DNA SEQUENCING MARKET, BY SEQUENCING SERVICES, 2021-2028 (IN $ MILLION)

    FIGURE 38: EUROPE DNA SEQUENCING MARKET, BY BIOINFORMATICS, 2021-2028 (IN $ MILLION)

    FIGURE 39: EUROPE DNA SEQUENCING MARKET, BY END-USER, IN 2020

    FIGURE 40: EUROPE DNA SEQUENCING MARKET, BY RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES, 2021-2028 (IN $ MILLION)

    FIGURE 41: EUROPE DNA SEQUENCING MARKET, BY PHARMACEUTICAL, 2021-2028 (IN $ MILLION)

    FIGURE 42: EUROPE DNA SEQUENCING MARKET, BY BIOTECHNOLOGY COMPANIES, 2021-2028 (IN $ MILLION)

    FIGURE 43: EUROPE DNA SEQUENCING MARKET, BY HOSPITALS & CLINICS, 2021-2028 (IN $ MILLION)

    FIGURE 44: EUROPE DNA SEQUENCING MARKET, BY OTHER END-USERS, 2021-2028 (IN $ MILLION)

    FIGURE 45: EUROPE DNA SEQUENCING MARKET, COUNTRY OUTLOOK, 2020 & 2028 (IN %)

    FIGURE 46: GERMANY DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 47: FRANCE DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 48: UNITED KINGDOM DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 49: ITALY DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 50: RUSSIA DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 51: BELGIUM DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 52: POLAND DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    FIGURE 53: REST OF EUROPE DNA SEQUENCING MARKET, 2021-2028 (IN $ MILLION)

    1. GEOGRAPHICAL ANALYSIS
      • EUROPE
        • MARKET SIZE & ESTIMATES
        • KEY GROWTH ENABLERS
        • KEY CHALLENGES
        • KEY PLAYERS
        • COUNTRY ANALYSIS
          • GERMANY
          • FRANCE
          • UNITED KINGDOM
          • ITALY
          • RUSSIA
          • BELGIUM
          • POLAND
          • REST OF EUROPE
    1. MARKET BY TECHNOLOGY
      • SEQUENCING BY SYNTHESIS
      • ION SEMICONDUCTOR SEQUENCING
      • CHAIN TERMINATION SEQUENCING
      • PYROSEQUENCING
      • SEQUENCING BY LIGATION (SBL)
      • SINGLE-MOLECULE REAL-TIME SEQUENCING (SMRT)
      • NANOPORE SEQUENCING
      • OTHER TECHNOLOGIES
    2. MARKET BY APPLICATION
      • BIOMARKER DISCOVERY
      • DIAGNOSTICS
      • REPRODUCTIVE HEALTH
      • PERSONALIZED MEDICINE
      • DRUG DISCOVERY
      • AGRICULTURE & ANIMAL RESEARCH
      • FORENSICS
      • OTHER APPLICATIONS
    3. MARKET BY PRODUCT
      • INSTRUMENTS & CONSUMABLES
        • INSTRUMENTS & CONSUMABLES TYPE
          • CONSUMABLES
          • INSTRUMENTS
        • INSTRUMENTS & CONSUMABLES PLATFORM
          • NGS (NEXT GENERATION SEQUENCING)
            • RNA SEQUENCING
            • TARGETED RESEQUENCING
            • WHOLE-EXOME SEQUENCING
            • WHOLE-GENOME SEQUENCING
            • CHIP SEQUENCING
            • DE NOVO SEQUENCING
            • METHYL SEQUENCING
          • SANGER
        • SEQUENCING SERVICES
        • BIOINFORMATICS
    1. MARKET BY END-USER
      • RESEARCH CENTERS AND ACADEMIC & GOVERNMENT INSTITUTES
      • PHARMACEUTICAL
      • BIOTECHNOLOGY COMPANIES
      • HOSPITALS & CLINICS
      • OTHER END-USERS

     

    To request a free sample copy of this report, please complete the form below :
    We offer 10% free customization including country-level data, niche applications and competitive landscape with every report.

      Choose License Type